today announced that iBio’s common stock has been approved for listing on the Nasdaq Capital Market and iBio will transfer its stock exchange listing to Nasdaq Capital Market from the NYSE American.

After its latest financial figures were worse than forecast, the company said there’s “substantial doubt” it can survive ...

While 2025 appears to be quite strong, so do the years beyond. Revenue backlog, a measure of the total contract value ...

Explore DocuSign stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DOCU. DocuSign Q4 Earnings: Revenue Beat, EPS Beat, Billings Up 11%, Shares Move Higher ...

ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in ...

Explore Strategy stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MSTR. Michael Saylor's Bitcoin 'Superpower Strategy': Could It Generate $106 Trillion ...

Vanguard Group Inc. now owns 10,505,006 shares of the athletic footwear retailer’s stock worth $228,589,000 ... Equities research analysts forecast that Foot Locker will post 1.23 EPS for ...

How do you forecast the price of gold ... Does the price of gold go up when the stock market goes down? The price of gold is often negatively correlated to the stock markets. When the markets go down, ...

The Dow Jones and S&P 500 posted robust gains Friday afternoon. Nvidia led the Dow and Ulta topped the S&P 500 on the stock ...

Of all the analysts covering PLTR, the stock is a consensus “Hold.” 24/7 Wall Street’s 12-month forecast projects Palantir’s stock price to be $120 with EPS coming in right at $0.43.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants ...